Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Van Maerken

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 23, 2010
A rapid and simple assay to determine pegylated erythropoietin in human serumTom Van Maerken, Annemieke Dhondt, Joris R Delanghe
Cancer Cell International|July 31, 2015
Inhibition of CDK4/6 as a novel therapeutic option for neuroblastomaAli Rihani, Jo Vandesompele, Frank Speleman, et al.
Computational and Structural Biotechnology Journal|May 15, 2015
Identification of miRNAs contributing to neuroblastoma chemoresistanceDuncan Ayers, Pieter Mestdagh, Tom Van Maerken, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based ValidationAlan Van Goethem, Pieter Mestdagh, Tom Van Maerken, et al.
Journal of Pediatric Hematology/Oncology|January 10, 2025
An Atypical Case of Neonatal Alloimmune ThrombocytopeniaGülsen Mutluoglu, Barbara De Muynck, Marie-Paule Emonds, et al.
Journal of Pediatric Hematology/Oncology|June 26, 2004
Familial and congenital polycythemias: a diagnostic approachTom Van Maerken, Kathleen Hunninck, Luc Callewaert, et al.
Clinical Biochemistry|January 18, 2018
Analytical and pre-analytical performance characteristics of a novel cartridge-type blood gas analyzer for point-of-care and laboratory testingMatthijs Oyaert, Tom Van Maerken, Silke Bridts, et al.
Journal of Cellular Physiology|February 10, 2009
Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastomaTom Van Maerken, Devanand Sarkar, Frank Speleman, et al.
Cancer Letters|November 23, 2013
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancerTom Van Maerken, Ali Rihani, Alan Van Goethem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compoundsKatleen De Preter, Sara De Brouwer, Tom Van Maerken, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 23, 2010
A rapid and simple assay to determine pegylated erythropoietin in human serumTom Van Maerken, Annemieke Dhondt, Joris R Delanghe
Cancer Cell International|July 31, 2015
Inhibition of CDK4/6 as a novel therapeutic option for neuroblastomaAli Rihani, Jo Vandesompele, Frank Speleman, et al.
Computational and Structural Biotechnology Journal|May 15, 2015
Identification of miRNAs contributing to neuroblastoma chemoresistanceDuncan Ayers, Pieter Mestdagh, Tom Van Maerken, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2017
MicroRNA Expression Analysis Using Small RNA Sequencing Discovery and RT-qPCR-Based ValidationAlan Van Goethem, Pieter Mestdagh, Tom Van Maerken, et al.
Journal of Pediatric Hematology/Oncology|January 10, 2025
An Atypical Case of Neonatal Alloimmune ThrombocytopeniaGülsen Mutluoglu, Barbara De Muynck, Marie-Paule Emonds, et al.
Journal of Pediatric Hematology/Oncology|June 26, 2004
Familial and congenital polycythemias: a diagnostic approachTom Van Maerken, Kathleen Hunninck, Luc Callewaert, et al.
Clinical Biochemistry|January 18, 2018
Analytical and pre-analytical performance characteristics of a novel cartridge-type blood gas analyzer for point-of-care and laboratory testingMatthijs Oyaert, Tom Van Maerken, Silke Bridts, et al.
Journal of Cellular Physiology|February 10, 2009
Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastomaTom Van Maerken, Devanand Sarkar, Frank Speleman, et al.
Cancer Letters|November 23, 2013
Pharmacologic activation of wild-type p53 by nutlin therapy in childhood cancerTom Van Maerken, Ali Rihani, Alan Van Goethem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2009
Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compoundsKatleen De Preter, Sara De Brouwer, Tom Van Maerken, et al.
Pageof 5